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Alternative RNA splicing (AS) regulates proteome
diversity, including isoform-specific expression of
several pluripotency genes. Here, we integrated
global gene expression and proteomic analyses
and identified a molecular signature suggesting a
central role for AS in maintaining human pluripo-
tent stem cell (hPSC) self-renewal. We demon-
strate that the splicing factor SFRS2 is an OCT4
target gene required for pluripotency. SFRS2
regulates AS of the methyl-CpG binding protein
MBD2, whose isoforms play opposing roles in
maintenance of and reprogramming to pluripo-
tency. Although both MDB2a and MBD2c are
enriched at the OCT4 and NANOG promoters,
MBD2a preferentially interacts with repressive
NuRD chromatin remodeling factors and promotes
hPSC differentiation, whereas overexpression of
MBD2c enhances reprogramming of fibroblasts
to pluripotency. The miR-301 and miR-302
families provide additional regulation by target-
ing SFRS2 and MDB2a. These data suggest
that OCT4, SFRS2, and MBD2 participate in
a positive feedback loop, regulating proteome
diversity in support of hPSC self-renewal and
reprogramming.92 Cell Stem Cell 15, 92–101, July 3, 2014 ª2014 Elsevier Inc.INTRODUCTION
The transcription factors OCT4, NANOG, and SOX2 are master
regulators of pluripotency in embryonic stem cells (ESCs) (De
Los Angeles et al., 2012) and, along with Klf4 and c-Myc, facili-
tate reprogramming of somatic cells into induced pluripotent
stem cells (iPSCs) (Park et al., 2008; Takahashi and Yamanaka,
2006). ESCs are indispensable models of early development,
whereas iPSCs hold great promise as cell-based therapeutics
that circumvent the immunologic and ethical hurdles of
embryo-derived cells. As a result, significant effort has been in-
vested in elucidating the mechanisms that underlie stem cell
function, with a particular emphasis on these core pluripotent
genes. Despite the requirement of OCT4, SOX2, and NANOG
in stem cell function (De Los Angeles et al., 2012), discrepancies
between ostensibly identical pluripotent cell lines (Gore et al.,
2011), in addition to the divergent lineage commitment proper-
ties of iPSCs derived from different adult tissues (Kim et al.,
2010), illustrate that the molecular network balancing self-
renewal, pluripotency, and lineage commitment is not yet
resolved.
Recently, functional genomics and molecular profiling ap-
proaches have been used to explore the broader role of the
core pluripotent factors in stem cell biology. These studies
expanded the set of genes that support pluripotency (Chia
et al., 2010) and defined a biochemical network centered around
OCT4, NANOG, and SOX2 that is highly enriched for genes
essential for development and stem cell function (Kim et al.,
2008). Furthermore, use of chromatin immunoprecipitation
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et al., 2010) has established the landscape of genetic targets
for several key pluripotent factors and defined correlations be-
tween promoter co-occupancy and transcriptional activation.
In parallel, genome-scale molecular measurement technologies
have been used to quantify differences in epigenetic modifica-
tions (Gifford et al., 2013; Xie et al., 2013), gene expression
(Tang et al., 2010), and protein translation (Ingolia et al., 2011)
in addition to protein expression and phosphorylation (Brill
et al., 2009; Phanstiel et al., 2011) between pluripotent stem cells
and other cell types. These data provide a rich resource of mo-
lecular information, although it remains challenging to generate
specific hypotheses from these disparate data types or establish
mechanistic links between these molecular profiles and the core
pluripotent factors.
Recently, alternative splicing (AS) has garnered attention as a
possible means by which stem cells regulate the expression
of gene and protein isoforms in order to support pluripotency
and self-renewal. Indeed, functional roles for alternatively
spliced gene products of NANOG, FOXP1, and Tcf7l1 have
been demonstrated (Das et al., 2011; Gabut et al., 2011; Salomo-
nis et al., 2010). In addition, the muscleblind-like family of RNA
binding proteins was found to repress pluripotency by mediating
expression of several somatic cell-specific protein isoforms,
including FOXP1 (Han et al., 2013). These data illustrate a gen-
eral role for AS in pluripotent cells; however, the specific splicing
factors and mechanistic links to the core pluripotent genes,
which work in concert to reinforce a ground state of self-renewal,
remain unresolved.
The splicing factor SFRS2 (also known as SC35) is essential
for embryonic development (Xiao et al., 2007) and regulates tran-
scription (Lin et al., 2008). Although several splicing substrates
have been identified (Lin et al., 2008), no pluripotency-specific
role has been established for SFRS2.
The methyl-DNA binding protein methyl-CpG binding domain
protein 2 (MBD2) comprises two predominant isoforms,MBD2a
andMBD2c (Hendrich and Bird, 1998), that share the sameMBD
domain but differ in the C-terminal region as a result of AS.MBD2
silences gene expression by binding to methylated DNA and re-
cruiting the nucleosome remodeling and deacetylation (NuRD)
complex (Zhang et al., 1999). Although NuRD has well-estab-
lished roles in development (Reynolds et al., 2012), the function
of MBD2 in stem cells is not well understood. In fact, data from
two recent studies are inconsistent with respect to the impact
ofMBD2 in somatic cell reprogramming (Lee et al., 2013; Onder
et al., 2012), although the possibility of isoform-specific function
was not considered.
In this study, we establish mechanistic links between OCT4
and SFRS2 and demonstrate that these factors work in concert
to regulate AS ofMBD2. Expression of specificMBD2 isoforms is
further regulated by the microRNA (miRNA) machinery, and we
find that the resulting gene products play opposing functional
roles with respect to self-renewal of human PSCs (hPSCs) and
reprogramming of fibroblasts. Consistent with these observa-
tions,MBD2 isoforms target the promoters ofOCT4 andNANOG
in human ESCs (hESCs) but differ dramatically in their ability
to biochemically interact with chromatin remodeling proteins.
Collectively, our results suggest a positive feedback loop
comprised of OCT4, SFRS2, and splice products of MBD2 thatregulates proteome diversity in order to support a self-renewing
ground state.
RESULTS
First, we sought to identify a molecular signature for pluripotency
that integrated gene and protein expression, in addition to pro-
tein phosphorylation in cells representing a broad range of ge-
netic backgrounds and cell fates (Figures S1A and S2 and Table
S1 available online). Independent hierarchical clustering of each
data type revealed that hPSCs from different tissue types exhibit
protein phosphorylation, gene transcription, and protein expres-
sion profiles that are clearly distinct from differentiated fibro-
blasts (DFs; Figure 1A), and each molecular class contributes a
subset of unique genes to the signature (Figure S1B). Notably,
the molecular divergence observed between pluripotent cells
and DFs was considerably higher than it was in hPSCs (Fig-
ure S1C); in addition we confirmed that the phosphorylation
signature was strongly linked to cell type rather than specific
culture conditions (Figure S1D). As is typical of high-throughput
measurements (Brill et al., 2009; Phanstiel et al., 2011; Tang
et al., 2010), classification of gene function within the pluripo-
tency signature based on gene ontology (GO) biological process
revealed enrichment of several disparate pathways (Figure 1B,
left).
There is growing appreciation that the principles of network
theory are applicable to human physiology whereby extended
physical, genetic, or metabolic relationships between bio-
molecules may have predictive power with respect to biological
outcomes (Bala´zsi et al., 2011; Vidal et al., 2011). Consistent
with this notion, we next asked whether interpretation of our
molecular signature data within the context of physical inter-
action networks would highlight specific cellular functions that
support self-renewal. Accordingly, we assessed the number
of physical interactions between constituent genes of the plu-
ripotency signature and three positive reference sets (PRSs)
of pluripotent factors derived from (1) literature survey, (2) a
recent functional genomics study, and (3) proteins defined as
biochemical interactors of Oct4 or Nanog (Figure S1E, Supple-
mental Experimental Procedures, and Table S2). This analysis
revealed that only members of the RNA splicing pathway are
consistently enriched across each measurement class (Fig-
ure 1B, right, and Table S3). Additional analysis (Supplemental
Experimental Procedures) of the splicing factors in our pluripo-
tent molecular signature suggested that the splicing factor
SFRS2 might be an important mediator of pluripotency (Fig-
ure 1C and Table S3).
Given the role of SFRS2 in AS, we next compared the levels of
spliced isoforms for 16,084 genes in hESCs and DFs and found
that the spliced products from 2,974 genes differed between
these cell types (Figure S3A and Table S4). Strikingly, we
observed that 1,424 of these were not otherwise represented
in the set of pluripotency signature genes (Figure S3A). As with
other molecular classes of the pluripotent signature (Figure 1B),
gene products subject to AS in hESCs are enriched for physical
interactions with the PRSs (Figure 1D and Table S3). Extension of
this analysis to GO annotation revealed a consistent enrichment
of factors related to transcription regulation and chromatin
modification (Figure S3B and Table S3); in total, we observedCell Stem Cell 15, 92–101, July 3, 2014 ª2014 Elsevier Inc. 93
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Figure 2. OCT4 and SFRS2 Display Interdependent Functional Links in hPSCs
(A and B) SFRS2 is required to support self-renewal. Lentiviral small hairpin RNA (shRNA)-mediated depletion of SFRS2 disrupted pluripotency in H1 ESCs as
monitored by colony morphology (A) and expression of OCT4 and NANOG (B).
(C) Depletion of OCT4 in H1 ESCs for 2 and 5 days led to a coordinate decrease in the expression of SFRS2.
(D) OCT4 selectively binds the proximal promoter region of SFRS2 in H1 ESCs.
(E) OCT4 depletion in human clone 9 iPSCs disrupts luciferase expression downstream of the native SFRS2 promoter.
(F) Mutation or deletion of the predicted OCT4 bindingmotif (ATGCCAAT) in the proximal SFRS2 promoter region decreased downstream luciferase expression in
clone 9 iPSCs. See also Figure S4. Error bars represent the mean ± SEM.
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Within the exon junction microarray data (Table S4), MBD2 had
the highest prediction score for AS between hESCs and DFs
(Figure 1E and Table S4).Figure 1. Analysis of the Molecular Signature Associated with hPSCs
(A) Independent hierarchical clustering of microarray and proteomic data demons
gene expression (left), protein expression (middle), and protein phosphorylation
(B) Left, analysis of pluripotency signature genes according to their membership in
pathways. Right, further analysis of genes within each GO-BP pathway and me
interactions with three positive reference sets (PRSs) of pluripotent factors (see F
that the RNA splicing pathway is strongly associated with pluripotency. Main., m
(C) Splicing factors within the pluripotent molecular signature were individually ran
as the top candidate.
(D) Alternatively spliced genes associated with hESCs are enriched for physical in
created by random selection (10,000 iterations) of identically sized gene sets fro
(E) The methyl-DNA binding protein MBD2 displays the strongest alternative sp
analysis (see the Supplemental Experimental Procedures).Next, we sought to establish specific links between SFRS2,
MBD2, and the machinery supporting pluripotency. Depletion
of endogenous SFRS2 disrupted self-renewal in hESCs as
gauged by cell morphology (Figure 2A), expression of OCT4Suggests a Central Regulatory Role for RNA Splicing
trated that hPSCs are molecularly distinct in comparison to DFs at the level of
(right).
gene ontology (GO) biological processes (BP) revealed enrichment of multiple
asurement class (gene, protein, and phosphoprotein) on the basis of physical
igure S1E, Supplemental Experimental Procedures, and Table S2) suggested
aintenance; Org., organization; Reg., regulation.
ked (see the Supplemental Experimental Procedures and Table S3) with SFRS2
teractions with PRSs of pluripotent factors. Null distributions (gray bars) were
m the background of all genes detected by exon-junction microarray.
licing pattern between hESCs and DFs on the basis of the linear regression
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Figure 3. MBD2 Isoform Expression Is Independently Regulated by the Splicing Factor SFRS2 and themiR-302 Family of miRNAs in hPSCs
(A) Exon and protein graph for the methyl-CpG binding protein MBD2. Dashed lines indicate splice sites. Protein segments corresponding to each exon are
annotated with predicted functional domains and primer locations.
(B and C) Verification of the distinct MBD2 isoforms in H1 ESCs and BJ DFs by quantitative RT-PCR (qRT-PCR; B) and western blotting (C).
(D) Lentiviral shRNA-mediated depletion of OCT4 and SFRS2 independently led to a significant increase in MBD2a expression along with reduced levels of
MBD2c after 5 days in H1 ESCs.
(E) Exogenously expressed SFRS2-FLAG-HA preferentially binds to MBD2 pre-mRNA at intron 2 (primer pairs II and III, each spanning into exons 2 and 3,
respectively) but not inside exon 2 (primer pair I) in H1 ESCs.
(F) miR-301b and miR-130b suppress luciferase expression in the context of wild-type, but not mutated, sequences corresponding to the 30 UTR of SFRS2 in
HeLa cells.
(G–I) miR-302 cluster members target the 30 UTR of MBD2 in an isoform-specific manner.
(G)miR-302 cluster members specifically suppressed luciferase expression upstream of the wild-type, but not mutated,MBD2a 30 UTR sequence in HeLa cells.
(H) miR-302 cluster members did not affect luciferase expression upstream of the MBD2c 30 UTR sequence in HeLa cells.
(I) Overexpression of miR-302 cluster members in 293T cells reduced expression of endogenous MBD2a. Error bars represent the mean ± SEM.
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Splicing of MBD2 Supports Self-Renewaland NANOG (Figure 2B), alkaline phosphatase staining (Fig-
ure S4A), and cell colony integrity (Figure S4B). We observed a
coordinate decrease in expression level of SFRS2 upon OCT4
depletion in hESCs (Figure 2C); importantly, this effect was
specific to SFRS2 and not observed for other splicing factors
(Figure S4C). Furthermore, we found that OCT4 bound directly
to the promoter of SFRS2 in hESCs (Figure 2D) and drove
expression of luciferase downstream of the native SFRS2 pro-96 Cell Stem Cell 15, 92–101, July 3, 2014 ª2014 Elsevier Inc.moter in vitro (Figure 2E). The specificity of this interaction was
confirmed by mutation or deletion within the predicted OCT4
binding site of the SFRS2 promoter (Figure 2F). These data pro-
vide evidence for functional and genetic links betweenOCT4 and
SFRS2 in hPSCs.
MBD2 comprises multiple isoforms (Hendrich and Bird, 1998)
(Figure 3A). We detected preferential gene- and protein-level
expression of the MBD2c and MBD2a isoforms in H1 ESCs
Cell Stem Cell
Splicing of MBD2 Supports Self-Renewaland BJ DFs, respectively (Figures 3B and 3C). Interestingly,
depletion of endogenous SFRS2 or OCT4 in hESCs led to a dra-
matic increase in expression of MBD2a and a reduction in
MBD2c (Figures 3D and S4D). Next, we probed for a direct
biochemical interaction between SFRS2 and MBD2 pre-mRNA
by assaying RNA that coprecipitated with exogenously ex-
pressed SFRS2-FLAG-HA. We observed that SFRS2 bound to
MBD2 pre-mRNA specifically at intron 2, preceding exon 3,
which is unique to the ESC-predominant MBD2c isoform (Fig-
ure 3E), suggesting that SFRS2 may mediate alternative splicing
of this methyl-DNA binding protein in hPSCs.
In addition, close inspection of the 30 untranslated region (30
UTR) of SFRS2 and MBD2a (but not MBD2c) revealed potential
binding motifs for miR-301 and miR-302, miRNA families that
are functionally associated with lineage commitment and self-
renewal (Figure S4E) (Bar et al., 2008). We confirmed that over-
expression ofmiR-301b andmiR-130b reduced luciferase driven
by the wild-type SFRS2 30 UTR, whereas mutation of the miR-
301 motif restored luciferase expression (Figure 3F). Similarly,
miR-302 specifically targeted the 30 UTR of MBD2a (Figure 3G)
but not that of MBD2c (Figure 3H). Indeed, we confirmed that
exogenous expression of miR-302 reduced levels of MBD2a
in vivo (Figure 3I). These data suggest that the miR-301 and
miR-302 families may independently regulate SFRS2 and
MBD2 in order to fine-tune the expression of MBD2 isoforms.
Next, we investigated the functional roles of MBD2 isoforms in
hPSCs. Overexpression ofMBD2a (Figures 4A and 4B) disrupted
pluripotency, as evidenced by cell morphology (Figure 4C) in
addition to reduced expression of OCT4, NANOG, and SOX2
(Figure 4D). In contrast, increased MBD2c levels had no effect
in hESC on the basis of these measures. However, the addition
of the ESC-specific MBD2c isoform (Figure 4E) to a cocktail of
reprogramming factors enhanced reprogramming efficiency in
BJ DFs, whereas exogenous expression ofMBD2a had no effect
(Figures 4F and 4G). These data suggested that MBD2a and
MBD2c play opposing roles in pluripotency. ChIP indicated
that MBD2a and MBD2c were enriched at OCT4 and NANOG
promoter regions in 293T cells as well as H1 ESCs (Figure 4H).
Interestingly, co- and reverse immunoprecipitation followed by
western blotting (Figures 4I and 4J) revealed that the somatic
cell-specific MBD2a isoform exhibits much higher affinity for
interaction with members of the transcriptionally repressive
NuRD complex, including HDAC1, HDAC2, RbAp46, MTA2,
and Mi-2 (Zhang et al., 1999). The specificity of the MBD2a-
NURD interaction was further confirmed by probing for SIN3A,
a corepressor (Zhang et al., 2005) independent of NuRD
that did not biochemically interact with either MBD2 isoform
(Figure 4I).
DISCUSSION
PSCs are phenotypically well defined but exhibit significant
molecular heterogeneity (Cahan and Daley, 2013). These obser-
vations suggest that the core pluripotent factors OCT4, SOX2,
and NANOG must balance a stochastic transcriptional ground
state but yet respond rapidly to exogenous cues in order to prop-
erly orchestrate the cell lineages required for life, all from a rela-
tively modest number of protein-coding genes (Wu et al., 2010).
Alternative splicing represents a likely pathway whereby the corepluripotency factors can dynamically regulate proteome diver-
sity to support high-fidelity lineage commitment (Wang et al.,
2008). Although several examples of alternatively spliced gene
products have been functionally validated in pluripotent cells
(Das et al., 2011; Gabut et al., 2011; Han et al., 2013; Salomonis
et al., 2010), a general framework that mechanistically links
OCT4, NANOG, or SOX2 with specific splicing factors, pre-
mRNA substrates, and canonical regulators of gene transcrip-
tion has yet to be described.
We found that the splicing factor SFRS2 was strongly repre-
sented within the pluripotent molecular signature and, moreover,
that OCT4 bound to SFRS2 promoters in vivo and drove lucif-
erase expression in vitro. These data establish interdependent
genetic and functional links between OCT4 and SFRS2 in
hPSCs. We confirmed a cell-type-specific expression pattern
forMBD2 isoforms, and found that SFRS2 biochemically targets
the pre-mRNA of this methyl-DNA binding protein. We also
observed a reciprocal link between OCT4 and MBD2a, mani-
fested at the level of gene expression and pluripotent pheno-
type. Interestingly, hESCs displayed distinct morphologies in
response to depletion of SRFR2 or overexpression of MBD2a,
suggesting that the splicing factor most likely targets additional
gene products; indeed, it is intriguing to speculate that the
pool of pluripotent-specific, alternatively spliced transcripts in
our exon-junction microarray data may be rich in previously un-
recognized gene isoforms that support self-renewal. Similarly,
use of next-generation DNA sequencing technologies may pro-
vide an exhaustive set of pluripotent-specific gene isoforms
and splicing factor gene targets. Notwithstanding a comprehen-
sive analysis of SFRS2 gene targets, our current results provide
compelling mechanistic evidence that the functional role of
OCT4 in pluripotent cells extends to the pathways that regulate
gene splicing.
Although the editing of pre-mRNA transcripts can be reconsti-
tuted in vitro, it has become clear that gene splicing in vivo is inti-
mately linked to transcription, chromatin structure, and histone
modifications (Braunschweig et al., 2013; Lin et al., 2008).
NuRD is a chromatin remodeling complex that is thought to pro-
mote lineage commitment of ESCs via silencing of pluripotency
genes (Reynolds et al., 2012). Although previouswork suggested
that NuRD was recruited to methylated DNA by MBD2 (Zhang
et al., 1999), we found that, while both MBD2a and MBD2c
bound to the promoter regions of OCT4 and NANOG in hPSCs,
only the somatic cell-specific MBD2a isoform biochemically in-
teracts with NuRD. Such isoform-specific recruitment of NuRD
may enable pluripotent cells to rapidly regulate their transcrip-
tional profiles in response to specific differentiation cues. Our
finding was recently corroborated in murine ESCs along with
data suggesting that the region of Mbd2a immediately C-termi-
nal to the MBD domain, but absent in Mbd2c, mediates interac-
tion with NuRDmembers (Baubec et al., 2013). Interestingly, two
recent computational studies suggested that tissue-specific
alternative splicing may mediate protein-protein interactions en
masse in order to support distinct phenotypes (Buljan et al.,
2012; Ellis et al., 2012). Our data provide a specific example
that fits this model whereby the activity of a chromatin remodel-
ing factor (NuRD) is mediated through interactions with protein
isoforms (MBD2) expressed in a cell-type-specific manner. Our
analysis further revealed that the pluripotent-specific MBD2cCell Stem Cell 15, 92–101, July 3, 2014 ª2014 Elsevier Inc. 97
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Splicing of MBD2 Supports Self-Renewalisoform augmented reprogramming efficiency of somatic cells,
whereas MBD2a had no effect. This observation is consistent
with a strongly repressive role for endogenous MBD2a-NuRD
complexes in somatic cells and potentially reconciles discrep-
ancies reported for the role of MBD2 in pluripotent cells (Lee
et al., 2013; Onder et al., 2012). Systematic titration of MBD2a
levels in the context of enforced MBD2c expression in somatic
cells may fully delineate the interplay of these isoforms and
reveal whether MBD2a represents a key hurdle to reprogram-
ming. The function of MBD family proteins and isoforms in
NuRD and in reprogramming are most likely complex, as exem-
plified by a recent report demonstrating that depletion of the
MBD3, also a component of NuRD, renders reprogramming
deterministic and highly efficient (Rais et al., 2013). Defining
the dynamics of these mutually exclusive MBD family-NuRD
complexes (Le Guezennec et al., 2006) along with their regula-
tory target genes in hPSCs should shed further light on the
mechanisms of somatic cell reprogramming.
Recent evidence suggests that the repressive activity of NuRD
is opposed by signaling pathways that support expression of
pluripotent factors, hence maintaining a stochastic ground state
in which ESCs self-renew but are transcriptionally poised for
lineage-specific differentiation (Hu and Wade, 2012). We found
that several serine residues on SFRS2 were preferentially phos-
phorylated in pluripotent cells (Table S1). The questions of which
signaling axis (e.g., AKT and SRPK) (Zhou et al., 2012) mediates
phosphorylation on SFRS2 andwhether this activity represents a
general mechanism to reinforce expression of pluripotent-spe-
cific gene isoforms in hPSCs are worthy of future study.
Noncoding RNA has emerged as an important posttranscrip-
tional regulatory pathway in pluripotent cells with functional links
established between specific micro- or long noncoding RNAs
(lncRNAs) and master regulatory transcription factors (Loewer
et al., 2010; Marson et al., 2008). The alternatively spliced
MBD2 isoforms harbor differences in both their 30 UTR and
protein-coding sequences. As a result, the somatic-cell-specific
MBD2a isoform is targeted by miR-302 family members. The 30
UTR of MBD2c does not appear to be subject to miR-mediated
suppression, although we did observe modest regulation of
SFRS2 by miR-301 family members in vitro. These results are
consistent with the notion that the microRNA machinery may
act synergistically with splicing factors and gene isoforms to
either enforce a self-renewing ground state or rapidly translate
lineage commitment signals into appropriate transcriptional pro-Figure 4. A General Model for Regulation of Proteome Diversity that S
(A–D) Lentiviral-mediated expression of MBD2a but not MBD2c disrupts pluripot
and western blotting (B). Pluripotency in H1 ESCs was assessed by colony morp
(E–G) Exogenous expression ofMBD2c, but notMBD2a, enhances reprogrammi
monitored by qRT-PCR. Reprogramming efficiency was assessed by the numb
replicates.
(H) Exogenous MBD2a and MBD2c independently bind to OCT4 and NANOG pr
(I and J) MBD2 interacts with the NuRD complex in an isoform-specific manner.
(I) Members of the NuRD transcription repressor complex (HDAC1, HDAC2, MTA2
but not FLAG-HA-MBD2c, in 293T cells. Neither MBD2 isoform interacts with th
(J) Coimmunoprecipitation of MTA2 in 293T cells overexpressing FLAG-HA-tagg
MTA2, a core NuRD complex member.
(K) Proposed model illustrating a putative positive feedback loop, in which the s
genes, regulates the expression of MBD2 isoforms that either support (MBD2c) or
of the NuRD complex. Error bars represent the mean ± SEM.grams. Further analysis will be required in order to determine the
full extent of miRNA-mediated regulation of proteome diversity
and whether lncRNAs (Wang et al., 2013) or other noncoding
sequences are also involved. Collectively, these data may allow
a quantitative assessment of the network topology including the
relative contribution of each node comprising a putative feed-
back loop linking the core pluripotent genes with the alternative
splicing apparatus and specific gene isoforms.
In summary, we delineate genetic, biochemical, and functional
links consistent with a general model (Figure 4K) in which the
master regulators of pluripotency (e.g., OCT4) act in concert
with splicing factors (e.g., SFRS2) and the miRNA machinery to
mediate protein diversity via alternative splicing (e.g., MBD2),
ultimately enforcing a pluripotent ground state.EXPERIMENTAL PROCEDURES
Cell Culture
hPSCs for proteomics and phosphoproteomics were maintained in mTeSR
media (STEMCELL Technologies) on six-well plates precoated with matrigel
(BD Bioscience) as previously described (Park et al., 2008).Chromatin Immunoprecipitation
ChIP was performed in H1 ESCs with anti-OCT4 (Santa Cruz Biotechnology).Coimmunoprecipitation
Protein coimmunoprecipitation was performed in 293T cells with anti-FLAG
gel (Sigma-Aldrich).Genome-wide Expression and Alternative Splicing Data
Gene expression (Table S1) and alternative splicing profiling (Table S4) was
performed with Affymetrix arrays.Proteomic Data
Samples were processed (Ficarro et al., 2009) for protein expression and
phosphorylation analyses by 3D reversed phase-strong anion exchange-
reversed phase liquid chromatography tandem mass spectrometry (Ficarro
et al., 2011). Native mass spectrometry data are available for download at
http://blaispathways.dfci.harvard.edu/mz/.Quantitative RT-PCR
For quantitative RT-PCR assays, relative gene-expression levels in BJ DFs or
infected H1 ESCs were calculated on the basis of the internal standard gene
TBP and normalized to those in either wild-type H1 ESCs or in H1 ESCs with
virus infection control, respectively.upports Self-Renewal in hPSCs
ency in H1 ESCs. Expression of MBD2 isoforms as monitored by qRT-PCR (A)
hology (C) and expression of OCT4, NANOG, and SOX2 (D).
ng efficiency in BJ DF. (E) Expression ofMBD2 isoforms in infected BJ DFs as
er (F) and fold change (G) of TRA-1-60 colonies measured across biological
omoter regions in H1 ESCs (top) and 293T cells (bottom).
, Mi-2, and RbAp46) coimmunoprecipitate with exogenous FLAG-HA-MBD2a,
e SIN3A-histone deacetylase complex.
ed MBD2 isoforms confirmed the preferential interaction between MBD2a and
plicing factor SFRS2, along with miRNAs controlled by the core pluripotency
oppose (MBD2a) expression ofOCT4,NANOG, and SOX2 through recruitment
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Relative occupancy values (fold enrichments) were calculated by determining
the immunoprecipitationefficiency (ratios of the amount of immunoprecipitated
RNA to that of the input sample) and normalized to the level observed by immu-
noprecipitation with nonspecific IgG, which was defined as 1.0.
Statistical Methods
The Student’s t test was used to estimate statistical significance (p < 0.05).
ACCESSION NUMBERS
All microarray data have been deposited in the NCBI Gene Expression
Omnibus under accession number GSE55673.
SUPPLEMENTAL INFORMATION
Supplemental Information contains Supplemental Experimental Procedures,
four figures, and four tables and can be found with this article online at
http://dx.doi.org/10.1016/j.stem.2014.04.002.
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